MetaVia to Present at Upcoming Investor and Industry Conferences

Provided By PR Newswire

Last update: Aug 26, 2025

CAMBRIDGE, Mass., Aug. 26, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced its participation in upcoming investor and industry conferences.